RECRUITING

Technology-enabled Management Versus Usual Care for Blood Pressure

Talk to us

Conditions

HypertensionHigh blood pressureDigital Health Mobile TechnologyCardiovascular riskClinical ResearchMedications

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Two arm parallel randomized clinical trial

Official Title

A Two-arm Parallel Randomized Clinical Trial of Implementation of Technology-enabled Management Versus Usual Care for Blood Pressure

Quick Facts

Study Start:2023-06-13
Study Completion:2025-03-15
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05479461

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:30 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 30-90 yrs.
  2. * Smartphone ownership
  3. * Office SBP: ≥ 140 mm Hg
  4. * ≤ 2 current anti-HTN meds
  5. * Able to add or dose-increase at least 2 of the following classes of medications: ACE-I/ARB, diuretic, calcium channel blocker, beta-blocker, mineralocorticoid receptor antagonists (i.e., at least 2 classes are available for addition or dose- increases after excluding intolerant medications and medications currently at maximum dose)
  6. * English or Spanish-speakers
  1. * Heart failure with reduced ejection fraction (EF \< 40%)
  2. * ESRD (GFR \<15)
  3. * Renal replacement therapy
  4. * Pregnant
  5. * Myocardial infarction or stroke within preceding 6 months
  6. * Hospitalization for hypertensive emergency or malignant hypertension within preceding 6 months
  7. * Prior solid organ transplantation
  8. * At the clinical discretion of the investigators
  9. * Enrolled in another clinical study

Contacts and Locations

Study Contact

Paul J Wang, MD
CONTACT
(650) 723-9363
pjwang@stanford.edu
Karma Lhamo, MSc
CONTACT
karmalh@stanford.edu

Principal Investigator

Paul J Wang, MD
PRINCIPAL_INVESTIGATOR
Stanford University

Study Locations (Sites)

Stanford Health Care
Palo Alto, California, 94305
United States

Collaborators and Investigators

Sponsor: Stanford University

  • Paul J Wang, MD, PRINCIPAL_INVESTIGATOR, Stanford University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-06-13
Study Completion Date2025-03-15

Study Record Updates

Study Start Date2023-06-13
Study Completion Date2025-03-15

Terms related to this study

Keywords Provided by Researchers

  • High blood pressure
  • Digital Health Mobile Technology
  • Cardiovascular risk
  • Clinical Research
  • Medications

Additional Relevant MeSH Terms

  • Hypertension